15-58179236-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020980.5(AQP9):c.604G>A(p.Val202Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000221 in 1,614,028 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020980.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AQP9 | NM_020980.5 | c.604G>A | p.Val202Ile | missense_variant | 5/6 | ENST00000219919.9 | |
AQP9 | NM_001320636.1 | c.409G>A | p.Val137Ile | missense_variant | 5/6 | ||
AQP9 | NM_001320635.2 | c.495+4200G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AQP9 | ENST00000219919.9 | c.604G>A | p.Val202Ile | missense_variant | 5/6 | 1 | NM_020980.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152180Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000836 AC: 21AN: 251224Hom.: 0 AF XY: 0.0000737 AC XY: 10AN XY: 135760
GnomAD4 exome AF: 0.000228 AC: 333AN: 1461848Hom.: 0 Cov.: 35 AF XY: 0.000199 AC XY: 145AN XY: 727228
GnomAD4 genome AF: 0.000151 AC: 23AN: 152180Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 13, 2024 | The c.604G>A (p.V202I) alteration is located in exon 5 (coding exon 5) of the AQP9 gene. This alteration results from a G to A substitution at nucleotide position 604, causing the valine (V) at amino acid position 202 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at